| Date | Title | Description |
| 02.04.2025 | Latest Innovation in Automation and AI/ML Presented at the 11th Annual Biopharma Partner Symposium | Digitalizing Biopharma R&D: The Genedata Biopharma Platform is the #1 enterprise software system for achieving operational excellence in biopharma R&D.
Top biopharmas and leading biotechs discuss new trends in AI/ML and share how th... |
| 08.03.2025 | The Unexpected Surge: How Unlikely Innovations Shape the Future of Business | Innovation often springs from the most unexpected sources. It’s like finding a diamond in the rough. The world of technology is littered with examples of breakthroughs that emerged from solving unrelated problems. Take the internet, for ins... |
| 06.03.2025 | Enrich Biosystems Welcomes Dr. Laszlo Radvanyi as Scientific Advisor | Dr. Laszlo Radvanyi
Accomplished immunologist with 30 years of experience conducting T cell research in both top-notch industry organizations and academic institutions to help life science tool company commercialize its groundbreaking techn... |
| 18.07.2024 | Merck KGaA, Darmstadt, Germany, to Acquire Unity-SC Strengthening its Offering for Artificial Intelligence Semiconductors | Unity-SC is an innovative provider of metrology and inspection equipment for semiconductor instrumentation delivering process control solutions in Advanced Packaging and Heterogeneous Integration for microchips and compound semiconductors w... |
| 21.06.2024 | Biocytogen Awarded U.S. Patent for RenLite® Common Light Chain Mouse Platform | BEIJING, June 21, 2024 /PRNewswire/ -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) announced United States Patent and Trademark Office (USPTO) patent grant for independently developed RenLite® fully ... |
| 27.04.2024 | India becoming attractive for clinical trials, says pharma industry leaders | - |
| 06.12.2023 | KGaA, Darmstadt, Germany, Collaborates on Open-Sourcing AI-Driven Experiment Planner | Bayesian optimization engine that already powers dozens of use cases at Merck KGaA, Darmstadt, Germany, now open sourced to foster adoption
Close partnership to enable the self-driving labs of tomorrow
Merck KGaA, Darmstadt, Germany, a lead... |
| 02.08.2022 | Investing in IDRx | HIV ravaged entire communities before antiretroviral cocktail therapies helped turn the tide. Cocktail therapies combine multiple drugs: Some hit parts of the replication machinery the virus uses to make copies of itself, others block its a... |
| 08.02.2022 | WuXi stock plummets, wiping nearly $10B off market value as US adds it to ‘unverified’ list | As Covid-19 has made it more difficult for US regulators to carry out routine inspections, WuXi Biologics has been hit with unverified status, causing its stock to plummet, and wipe $9.9 billion off of its market value ... |
| 08.02.2022 | Covid-19 jab production has stopped at J&J's vaccine birthplace | A J&J manufacturing site in Leiden, Netherlands has halted its production of Covid-19 vaccines, in favor of making another vaccine that The New York Times says is more profitable.
The halt is not permanent, the compa... |
| 07.02.2022 | MilliporeSigma Announces Organizational Transformation to Strengthen CDMO Offering and Accelerate Future Growth | DARMSTADT, Germany, Feb. 7, 2022 /PRNewswire/ -- MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced several organizational changes and a new... |
| 07.02.2022 | Merck KGaA shuffles organization to boost its CDMO operation as a top exec retires | Merck KGaA is reorganizing after a key supply chain executive’s retirement, building out a new life science unit with a fully integrated CDMO and contract testing service business.
Dirk Lange
In Burlington, MA, about... |
| 30.12.2021 | MilliporeSigma Announces $136.7 Million U.S. Government Contract Award for New Lateral Flow Membrane Production Facility in Sheboygan, Wisconsin | BURLINGTON, Mass., Dec. 29, 2021 /PRNewswire/ -- MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that it has been awarded a $136.7M USD c... |
| 20.12.2021 | Merck Buys Chord Therapeutics | Merck KGaA, a global science and technology company which operates across healthcare, life science and electronics, acquired Chord Therapeutics, a Geneva, Switzerland-based clinical stage biopharmaceutical company developing drugs for rare ... |
| 11.12.2021 | Merck KGaA, Darmstadt, Germany, Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million | Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the expansion of its strategic, corporate venture capital arm M Ventures |
| 28.10.2021 | Siemens and Merck KGaA, Darmstadt, Germany, Collaborate to Boost Machine-to-Machine NA | Press
Nuremberg, October 28, 2021
Siemens and Merck KGaA, Darmstadt, Germany, Collaborate to Boost Machine-to- Machine Trust in Industrial Value Chains
Both companies kick off developments to ensure quality and trust in a machine-to-machine... |
| 14.09.2021 | Merck : Group CFO Presentation | Financial perspective
Marcus Kuhnert, CFO
2nd Virtual CMD - September 9, 2021
Disclaimer
Publication of Merck KGaA, Darmstadt, Germany. In the United States and Canada the group of companies affiliated with Merck KGaA, Darmstadt, Germany op... |
| 06.08.2021 | Oncolytics Biotech® Reports 2021 Second Quarter Development Highlights and Financial Results | - Clinical AWARE-1 trial achieves primary endpoint and confirms that pelareorep is an immunotherapeutic agent which synergizes with checkpoint inhibitors: Validation of clinical development strategy in breast cancer
- Phase 2 BRACELET-1 (br... |
| 06.08.2021 | Oncolytics Biotech® Reports 2021 Second Quarter Development Highlights and Financial Results | |
| 07.05.2021 | Oncolytics Biotech® Reports 2021 First Quarter Development Highlights and Financial Results | |
| 07.05.2021 | Oncolytics Biotech® Reports 2021 First Quarter Development Highlights and Financial Results | - AWARE-1 clinical data validate clinical development strategy by confirming pelareorep's anti-tumor mechanism of action known to be associated with improved patient outcomes and ability to synergize with checkpoint inhibitors
- Preclinical... |
| 03.04.2021 | Merck : Corporate Governance Statement 2020 (Version March 2021) | CORPORATE GOVERNANCE
150
Capital Structure and Corporate Bodies of Merck KGaA, Darmstadt, Germany
151 Statement on Corporate Governance including Compensation Report
187 Report of the Supervisory Board
191 Objectives of the Supervisory Boar... |
| 15.03.2021 | Vivek Ramaswamy's LNP delivery tech play Genevant scores $600M licensing deal from Takeda for nucleic acid therapies | With mRNA vaccines in high demand and new RNA therapeutics crowding onto the market, the demand for lipid nanoparticles has never been higher. Now, one of serial entrepreneur Vivek Ramaswamy’s Vant outfits has scored a... |
| 05.03.2021 | Oncolytics Biotech® Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights | |
| 04.03.2021 | MERCK KGAA
Merck : Corporate Governance Statement 2020 (Version March 2021) | CORPORATE GOVERNANCE
150
Capital Structure and Corporate Bodies of Merck KGaA, Darmstadt, Germany
151 Statement on Corporate Governance including Compensation Report
187 Report of the Supervisory Board
191 Objectives of the Supervisory Boar... |
| 03.03.2021 | The key ingredient that could hold back vaccine manufacturing | As vaccines are distributed around the world, an effective end to the Covid-19 pandemic seems to be on the horizon. There’s a new vaccine from Johnson & Johnson now being delivered, with supplies soon to be boosted by a deal with the ph... |
| 09.12.2020 | Mitsubishi joins Mosa Meat’s second Series B close at $20m | Mosa Meat, the Netherlands-based startup that built the world’s first ‘lab-grown’ beef burger back in 2013, has announced a second closing of its Series B round at $20 million.
That takes its total for the round so far to $75 million, follo... |
| 04.12.2020 | Merck: “We Expect Major Innovation Breakthroughs to Happen During the Next Ten Years” | Merck KGaA, of Darmstadt, Germany, is a top science and technology company led by a team of specialists from diverse scientific fields in the areas of healthcare, life science and performance materials. The company is now working on the cre... |
| 12.10.2020 | News briefing: Gilead reveals more filgotinib data; Seagen and Astellas report new cohort for Padcev | Two months after being rejected by the FDA, Gilead still hasn’t decided what to do with filgotinib. And now they have another batch of positive data to weigh in the balance.
Investigators say the drug came through in their... |
| 06.10.2020 | Occupied with immunology and cancer, Merck KGaA hands off osteoarthritis drug to Novartis for €50M cash | By the time Merck KGaA published promising Phase II data for sprifermin — once tapped as a big prospect for the ailing R&D group — late last year, the German drugmaker made clear it was looking for a partner to take over its ... |
| 09.09.2020 | News briefing: Catalent, Merck KGaA make big investments in manufacturing ops; J&J teams with Datavant on data sharing projects | We’re continuing to see big investments in the global biopharma manufacturing infrastructure.
Wednesday morning Catalent put out the word that it is investing $130 million in its late-stage ops at its gene therapy fa... |
| 13.08.2020 | MERCK KGAA
Second Quarter: Group Remains on Course in a Challenging Environment | News Release
Your Contact
Media Relations andreas.cezanne@emdgroup.com Phone: +49 6151 72-45946
Investor Relations investor.relations@emdgroup.com Phone: +49 6151 72-3321
August 6, 2020
Second Quarter: Group Remains on Course in a Challengi... |
| 06.08.2020 | MERCK KGAA
Second Quarter: Group Remains on Course in a Challenging Environment | Overview of Q2 2020
Sales rise by 3.7% to € 4.1 billion, EBITDA pre declines by -5.7% to € 1.1 billion
Healthcare and Performance Materials more strongly affected by the Covid-19 pandemic than Life Science
Process Solutions drives growth of... |
| 21.04.2020 | Merck KGaA adds to gene therapy manufacturing boom with €100M facility in California | Add a new, €100 million California facility to the growing gene therapy infrastructure.
Merck KGaA announced they are opening a second gene therapy and viral vector factory in Carlsbad, California. The new center... |
| 01.04.2020 | Coronavirus Business Tracker: How The Private Sector Is Fighting The Covid-19 Pandemic | Alain Mérieux, founder of BioMérieux.AFP via Getty Images |
| 20.03.2020 | Covid-19 roundup: Italy death toll officially tops China; US company plans roll out of at-home specimen collection kits | In a first, China reported on Thursday that there were no new locally-transmitted coronavirus cases for the first time since the pandemic began, while President Trump implied treatments to fight the coronavirus scourge w... |
| 12.11.2019 | Amgen axes 149 of its staff in Cambridge office; Evotec, MilliporeSigma enter research pact | → Amgen has submitted a Worker Adjustment and Retraining Act (WARN) — a warning of impending mass layoffs 60 days in advance of the date — to the state of Massachusetts in the wake of the company’s exodus from the neuro... |
| 02.10.2019 | Trade agreement drug monopoly is obsolete given faster, better drug discovery | For decades, the brand-name drug industry has relentlessly promoted the message that any reduction in its government-protected monopolies would have detrimental effects on innovation. Members of Congress on both sides of the aisle have take... |
| 25.06.2019 | Accelerators seeking startups focused on cancer | They include Illumina Accelerator, Merck Accelerator and The Cedars-Sinai Accelerator
Editor's note: Vator, HP and UCSF's salon - "Future of Clinics" is on June 27. Need relationships to grow your digital health startup? Register ... |
| 02.05.2019 | Africa Roundup: Jumia’s IPO, DHL launches Africa e-Shop, Cathay’s $168M VC fund, ConnectMed acquired | The biggest news in a month of weighty African headlines was Jumia listing on the New York Stock Exchange.
After filing SEC IPO docs in March, the Pan-African e-commerce company’s shares began trading on the NYSE April 12, opening at $14.50... |
| 17.01.2019 | This Algorithm Finds Ways to Make Life-Saving Drugs While Avoiding Patents | A team of Polish and South Korean researchers made a computer program that develops new production methods for existing life-saving drugs without infringing on the drug patents of pharmaceutical companies.
The researchers expect that their ... |
| 23.08.2018 | ApoGen raises additional $4M, adds three biotech vets in pursuit of better cancer treatment | (Bigstock Photo)
Biotech startup ApoGen, which is researching solutions to drug-resistant cancers, is moving into a new phase of development. The company announced Thursday that it has raised an additional $4 million as part of its series A... |
| 18.07.2018 | It Shouldn’t Be Called ‘Clean Meat’ But It Will be Clean, says Cultured Meat’s Founder | “I don’t use the term clean meat for a couple of reasons; it can’t translate into Dutch, French or German, and it kind of suggests that current meat is dirty, which I think unnecessarily criminalizes the meat industry and there’s no need fo... |
| 27.03.2018 | Merck KGaA adopts Medisafe medication adherence tool for patients with chronic conditions | Boston and Israeli digital health business Medisafe has inked a deal with Merck KGaA, based in Darmstadt Germany, to roll out customized versions of its mobile medication management and adherence program for drugs taken by people with cardi... |
| 09.03.2018 | Displaying Futures Award seeks for Smart Medical Ideas (Sponsored) | Merck KGaA, Darmstadt, Germany, a leading science and technology company, recently debuted its third Displaying Futures Award. This year the award focuses on smart medical devices, calling for proposals on innovations in the areas of wearab... |
| 15.02.2018 | Pfizer, Merck KGaA say their PD-L1 Bavencio also flunked PhIII in the all-important lung cancer field | Playing catch-up in the crowded PD-1/L1 field in cancer R&D is proving particularly tough for Merck KGaA and Pfizer $PFE.
The partners reported this morning that their Phase III lung cancer study JAVELIN Lung 200 failed t... |
| 13.07.2017 | Merck KGaA life sciences reorg will claim 200 jobs; Tesaro shares sink on new report discounting buyout talk | → Merck KGaA is winnowing out 200 jobs over the next five years as it reorganizes its European life sciences business. The company is consolidating the manual filling and distribution of non-regulated laborator... |
| 21.06.2017 | Sarepta to collaborate with Genethon on DMD gene therapy; Chinese investors pull back on Pluristem investment | → Cambridge, MA-based Sarepta $SRPT is doubling down on new work focused on developing a gene therapy for Duchenne muscular dystrophy. The biotech inked a deal to collaborate with the nonprofit Genethon, which has been wo... |
| 20.06.2017 | Merck Ventures, CRUK launch new immuno-oncology spinout biotech iOnctura | German Merck, fresh off it and partner Pfizer’s FDA approval for their checkpoint inhibitor Bavencio, and R&D charity CRUK are coming together to launch a biotech focused on immuno-oncology.
The company, called iOnctura, has come to lif... |
| 12.01.2017 | With billions of dollars at stake, Merck and Palantir partner to discover drugs faster | Merck, the German multinational chemical and pharmaceutical company, is teaming up with Silicon Valley’s highest-profile data and analysis software company, Palantir, to more quickly develop new drugs and, hopefully, improve patient outcome... |
| 17.11.2015 | Merck to Produce Anti-Diabetes Meds in Algeria to Improve Care of Patients | Merck, a leading life sciences and technology company, today announced the commissioning of its anti-diabetes medicine production unit for the treatment of diabetes and high blood pressure. A joint venture project has subsequently been set ... |
| 23.07.2015 | Daily funding roundup - July 23, 2015 | Flipboard raised $50M; Notion Capital launched $120M; CarPrice closed $40M
CarPrice wants to be the company that brings the process of buying used cars in Russia online closed $40 million in Series B funding. The round was led by Baring Vos... |
| - | See the 17 fastest-growing biotech and pharma companies that hired thousands of new workers or grew at least 150% | Insider This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Insider analyzed almost 500 SEC reports to find the fastest-growing drug companies right now.
We found 17 companies that grew their... |
| - | Merck KGaA adopts Medisafe medication adherence tool for patients with chronic conditions | Boston and Israeli digital health business Medisafe has inked a deal with Merck KGaA, based in Darmstadt Germany, to roll out customized versions of its mobile medication management and adherence program for drugs taken by people with cardi... |
